# US 2021/0077951 A1 · Tangential flow filter system for the filtration of materials from biologic fluids

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0077951 A1
- Document ID: US20210077951A1
- Status: Published application
- Kind: A1
- Application number: 17/108,775
- Filed: 2020-12-01
- Published: 2021-03-18
- Earliest claimed: 2015-08-05
- Assignees: Minnetronix, Inc.
- Applicants: Minnetronix, Inc.
- Inventors: EMILY ROLFES MEYERING; GARY SEIM; ABHI VASE; BEN KREHBIEL; BLAKE HEDSTROM; AARON MCCABE
- Web page: https://patentgrep.com/patent/US20210077951A1

## CPC

- B01D 61/58: Multistep processes
- A61M 1/88: {Draining devices having means for processing the drained fluid, e.g. an absorber (for liposuction A61M1/892)}
- A61M 1/884: {Draining devices provided with means for filtering out the harmless water content before discarding the drainage container}
- A61M 25/00: Catheters; Hollow probes (dilators A61M29/00; {peritoneal catheters A61M1/285; tracheal tubes A61M16/04; for drainage A61M27/00; for uterus, vagina or rectum A61M31/00} ; for measuring or testing A61B; {materials for catheters A61L29/00})
- B01D 61/145: {Ultrafiltration}
- B01D 61/147: {Microfiltration}
- B01D 61/149: {Multistep processes comprising different kinds of membrane processes selected from ultrafiltration or microfiltration}
- B01D 61/22: Controlling or regulating
- B01D 61/32: Controlling or regulating
- A61M 27/006: {Cerebrospinal drainage; Accessories therefor, e.g. valves}
- A61M 2202/0464: Cerebrospinal fluid
- A61M 2205/3327: Measuring
- A61M 2205/3334: Measuring or controlling the flow rate
- A61M 2205/75: with filters
- A61M 2206/11: Laminar flow
- A61M 2230/005: Parameter used as control input for the apparatus
- B01D 2311/06: Specific process operations in the permeate stream
- B01D 2311/12: Addition of chemical agents
- B01D 2311/16: Flow or flux control
- B01D 2313/12: Specific discharge elements
- B01D 2313/18: Specific valves
- B01D 2315/08: Fully permeating type; Dead-end filtration
- B01D 2315/10: Cross-flow filtration
- B01D 2317/022: Reject series
- B01D 2317/04: Elements in parallel
- B01D 2317/08: Use of membrane modules of different kinds
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Systems and methods for filtering materials from biologic fluids are discussed. Embodiments may be used to filter cerebrospinal fluid (CSF) from a human or animal subject. The method may include the steps of withdrawing fluid comprising CSF, filtering the volume into permeate and retentate by passing the fluid through a tangential flow filter, and returning the permeate to the subject. During operation of the system, various parameters may be modified, such as flow rate.

## Claims

### Claim 1

A system for filtering materials from cerebrospinal fluid (CSF) of a human or animal subject, the system comprising:
a filtration system for withdrawing a first volume of a fluid comprising CSF from a CSF-containing space of the subject at a first flow rate, the filtration system operating according to a set of operation parameters;
a tangential flow filter for filtering the first volume of the fluid into a permeate and a retentate;
a sensor for measuring a characteristic of the fluid, wherein the characteristic comprises a ratio of the permeate to the retentate;
wherein the filtration system is designed to return a second volume of the permeate to the CSF-containing space of the subject at a second flow rate; and
wherein the filtration system is designed to update a parameter of the set of operation parameters when the difference between the first volume and the second volume exceeds a predetermined threshold.

### Claim 2 (depends on 1)

The system of claim 1, wherein the filtration system is in fluid connection with the CSF-containing space of the subject via a multi-lumen catheter inserted at least partially within the CSF-containing space.

### Claim 3 (depends on 1)

The system of claim 1, wherein the parameter comprises the first flow rate and the second flow rate.

### Claim 4 (depends on 3)

The system of claim 3, wherein updating the parameter of the set of operation parameters comprises equalizing the first flow rate and the second flow rate.

### Claim 5 (depends on 1)

The system of claim 1, wherein the predetermined threshold is a difference between the first volume and the permeate volume that is predicted to induce a spinal headache.

### Claim 6 (depends on 5)

The system of claim 5, wherein the subject is a human subject and the difference between the first volume and the permeate volume that is predicted to induce a spinal headache is between about 35 milliliters per hour and 45 milliliters per hour.

### Claim 7 (depends on 1)

The system of claim 1, wherein the parameter of the set of operation parameters comprises a flow rate parameter and updating the parameter of the set of operation parameters causes the first and second flow rate to decrease.

### Claim 8 (depends on 1)

The system of claim 1, wherein the first flow rate is between approximately 0.04 milliliters per minute and approximately 30 milliliters per minute.

### Claim 9 (depends on 1)

The system of claim 1, wherein the filtration system is designed to add a therapeutic agent to the second volume of the permeate prior to returning the second volume of the permeate to the CSF-containing space.

### Claim 10 (depends on 1)

The system of claim 1, wherein the filtration system is designed to add artificial CSF to the second volume of the permeate prior to returning the second volume of the permeate to the CSF-containing space.

### Claim 11 (depends on 1)

The system of claim 1, further comprising:
a second sensor for measuring a second characteristic of the fluid, wherein the second characteristic is an absolute retentate flow rate;
wherein the filtration system is designed to determine whether the second characteristic passes a second threshold, where the second threshold is a range of acceptable retentate flow rates; and
wherein the filtration system is designed to update a second parameter of the set of operation parameters to cause the absolute retentate flow rate to return to within the range of acceptable retentate flow rates.

### Claim 12

A system for filtering cerebrospinal fluid (CSF) of a human or animal subject, the method comprising:
a multi-lumen catheter designed to be introduced into a CSF-containing space of the subject, the catheter having a first port and a second port;
wherein the multi-lumen catheter is designed to withdraw a volume of fluid comprising CSF from the CSF-containing space through the first port at a withdrawal flow rate;
a tangential flow filter for filtering the volume of fluid into permeate and retentate by passing the volume of fluid through the tangential flow filter at a pressure and a filter flow rate; and
wherein the multi-lumen catheter is designed to return the permeate to the CSF-containing space of the subject through the second port at a return flow rate; and
wherein the system is designed to increase the withdrawal flow rate and the return flow rate responsive to determining that a ratio of permeate to retentate has increased.

### Claim 13 (depends on 12)

The system of claim 12, wherein the system is designed to increase at least one of the pressure and the filter flow rate responsive to determining the ratio of permeate to retentate has increased.

### Claim 14 (depends on 13)

The system of claim 13, wherein both the pressure and the filter flow rate are increased responsive to determining the ratio of permeate to retentate has increased.

### Claim 15 (depends on 14)

The system of claim 14, wherein the withdrawal flow rate and the return flow rate are substantially the same.

### Claim 16

A system for filtering cerebrospinal fluid, the system comprising:
a catheter and pump assembly configured to withdraw a first volume of CSF from a patient at a first flow rate;
a filter in fluid communication with the catheter and pump assembly, the filter being configured to filter the first volume of fluid into a permeate volume and a retentate;
wherein the catheter and pump assembly is configured to return the permeate volume to the patient at a second flow rate;
a processor for determining a difference between the first volume and the permeate volume; and
wherein the catheter and pump assembly is configured to modify the first flow rate, the second flow rate, or both when the difference between the first volume and the permeate volume exceeds a predetermined threshold.

### Claim 17 (depends on 16)

The system of claim 16, wherein the predetermined threshold is a difference between the first volume and the permeate volume that is predicted to induce a spinal headache.

### Claim 18 (depends on 17)

The system of claim 17, wherein the difference between the first volume and the permeate volume that is predicted to induce a spinal headache is between about 35 milliliters per hour and 45 milliliters per hour.

### Claim 19 (depends on 16)

The system of claim 16, wherein the catheter and pump assembly is configured to add a therapeutic agent to the permeate volume.

### Claim 20 (depends on 16)

The system of claim 16, wherein the catheter and pump assembly is configured to add artificial CSF to the permeate volume.
